Truncation of tau at E391 promotes early pathologic changes in transgenic mice

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 11, 2011, Pages 1006-1019

  McMillan, Pamela J ^a,b   Kraemer, Brian C ^a,c   Robinson, Linda ^a   Leverenz, James B ^a,b,c   Raskind, Murray ^a,b   Schellenberg, Gerard ^d  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b Department of Psychiatry and Behavioral Sciences   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aggregation; Alzheimer disease; Tau; Transgenic mice; Truncation

Indexed keywords

GLUTAMIC ACID; GLUTAMIC ACID 391; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; IMMUNOREACTIVITY; MOUSE; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE; WILD TYPE;

ADENOSINE TRIPHOSPHATASES; ALZHEIMER DISEASE; ANIMALS; BRAIN; CATION TRANSPORT PROTEINS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NEURONS; PHOSPHORYLATION; PLAQUE, AMYLOID; TAU PROTEINS;

EID: 80054896626     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31823557fb     Document Type: Article

References (53)

1. Buee L, Bussiere T, Buee-Scherrer V, et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 2000;33:95-130
2. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001;24:1121-59 (Pubitemid 32695256)
3. Mandelkow E, von Bergen M, Biernat J, et al. Structural principles of tau and the paired helical filaments of Alzheimer's disease. Brain Pathol 2007;17:83-90
4. Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging 2001;22:89-107 (Pubitemid 32333002)
5. Congdon EE, Duff KE. Is tau aggregation toxic or protective? J Alzheimers Dis 2008;14:453-57
6. Andreadis A. Tau gene alternative splicing: Expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim Biophys Acta 2005;1739:91-103 (Pubitemid 40018532)
7. Garcia-Sierra F, Mondragon-Rodriguez S, Basurto-Islas G. Truncation of tau protein and its pathological significance in Alzheimer's disease. J Alzheimers Dis 2008;14:401-9
8. Mena R, Edwards PC, Harrington CR, et al. Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease. Acta Neuropathol 1996;91:633-41 (Pubitemid 26166678)
9. Novak M, Jakes R, Edwards PC, et al. Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc Natl Acad Sci USA 1991;88:5837-41 (Pubitemid 21914841)
10. Basurto-Islas G, Luna-Munoz J, Guillozet-Bongaarts AL, et al. Accumulation of aspartic acid421-and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J Neuropathol Exp Neurol 2008;67:470-83 (Pubitemid 351653539)
11. Abraha A, Ghoshal N, Gamblin TC, et al. C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J Cell Sci 2000;113(Pt 21): 3737-45
12. Garcia-Sierra F, Wischik CM, Harrington CR, et al. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease. J Chem Neuroanat 2001;22:65-77 (Pubitemid 32695510)
13. de Silva R, Lashley T, Gibb G, et al. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 2003;29:288-302 (Pubitemid 36718177)
14. Kosik KS, Orecchio LD, Binder L, et al. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1988;1:817-25
15. Ishihara T, Higuchi M, Zhang B, et al. Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments. J Neurosci 2001;21:6026-35 (Pubitemid 32737736)
16. Carmel G, Mager EM, Binder LI, et al. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 1996;271:32789-95 (Pubitemid 27008707)
17. Jicha GA, Berenfeld B, Davies P. Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease. J Neurosci Res 1999;55:713-23 (Pubitemid 29173485)
18. Jicha GA, Bowser R, Kazam IG, et al. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 1997;48:128-32 (Pubitemid 27181338)
19. Uchihara T, Duyckaerts C, Seilhean D, et al. Exclusive induction of tau2 epitope in microglia/macrophages in inflammatory lesions-tautwopathy distinct from degenerative tauopathies. Acta Neuropathol 2005;109: 159-64 (Pubitemid 40468385)
20. Probst A, Gotz J, Wiederhold KH, et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol 2000;99:469-81 (Pubitemid 30201307)
21. Ishihara T, Hong M, Zhang B, et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 1999;24:751-62
22. Guthrie CR, Schellenberg GD, Kraemer BC. SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans. Hum Mol Genet 2009;18:1825-38
23. Janke C, Beck M, Stahl T, et al. Phylogenetic diversity of the expression of the microtubule-associated protein tau: Implications for neurodegenerative disorders. Brain Res Mol Brain Res 1999;68:119-28 (Pubitemid 29244000)
24. Kampers T, Pangalos M, Geerts H, et al. Assembly of paired helical filaments from mouse tau: Implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease. FEBS Lett 1999; 451:39-44 (Pubitemid 29236169)
25. Takuma H, Arawaka S, Mori H. Isoforms changes of tau protein during development in various species. Brain Res Dev Brain Res 2003;142: 121-27 (Pubitemid 36593156)
26. Bullmann T, de Silva R, Holzer M, et al. Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus. Hippocampus 2007;17:98-102 (Pubitemid 46362604)
27. McMillan P, Korvatska E, Poorkaj P, et al. Tau isoform regulation is region-and cell-specific in mouse brain. J Comp Neurol 2008;511: 788-803
28. Binder LI, Frankfurter A, Rebhun LI. The distribution of tau in the mammalian central nervous system. J Cell Biol 1985;101:1371-78 (Pubitemid 16203754)
29. Trojanowski JQ, Schuck T, Schmidt ML, et al. Distribution of tau proteins in the normal human central and peripheral nervous system. J Histochem Cytochem 1989;37:209-15 (Pubitemid 19039170)
30. Andorfer C, Kress Y, Espinoza M, et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem 2003;86:582-90 (Pubitemid 36897439)
31. Eckermann K, Mocanu MM, Khlistunova I, et al. The beta-propensity of tau determines aggregation and synaptic loss in inducible mouse models of tauopathy. J Biol Chem 2007;282:31755-65 (Pubitemid 350044904)
32. Yoshiyama Y, Higuchi M, Zhang B, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007;53:337-51 (Pubitemid 46161268)
33. Avila J, Perez M, Lim F, et al. Tau in neurodegenerative diseases: tau phosphorylation and assembly. Neurotox Res 2004;6:477-82
34. Grundke-Iqbal I, Iqbal K, Tung YC, et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83:4913-17
35. Kowall NW, Kosik KS. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease. Ann Neurol 1987;22:639-43 (Pubitemid 17162909)
36. Spittaels K, Van den Haute C, Van Dorpe J, et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 1999;155:2153-65
37. Filipcik P, Zilka N, Bugos O, et al. First transgenic rat model developing progressive cortical neurofibrillary tangles. Neurobiol Aging [published online ahead of print December 31, 2010] doi:10.1016/j. neurobiolaging. 2010.10.015.
38. Zilka N, Filipcik P, Koson P, et al. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 2006;580:3582-88 (Pubitemid 43902790)
39. von Bergen M, Barghorn S, Biernat J, et al. Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim Biophys Acta 2005;1739:158-66 (Pubitemid 40018535)
40. Mocanu MM, Nissen A, Eckermann K, et al. The potential for betastructure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous tau in inducible mouse models of tauopathy. J Neurosci 2008;28:737-48 (Pubitemid 351159036)
41. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
42. Konzack S, Thies E, Marx A, et al. Swimming against the tide: Mobility of the microtubule-associated protein tau in neurons. J Neurosci 2007;27: 9916-27 (Pubitemid 47404013)
43. Uboga NV, Price JL. Formation of diffuse and fibrillar tangles in aging and early Alzheimer's disease. Neurobiol Aging 2000;21:1-10 (Pubitemid 30224779)
44. Weaver CL, Espinoza M, Kress Y, et al. Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol Aging 2000;21:719-27
45. Wolozin BL, Pruchnicki A, Dickson DW, et al. A neuronal antigen in the brains of Alzheimer patients. Science 1986;232:648-50 (Pubitemid 16061977)
46. Garcia-Sierra F, Ghoshal N, Quinn B, et al. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. J Alzheimers Dis 2003;5:65-77 (Pubitemid 36582767)
47. Claiborne BJ, Amaral DG, Cowan WM. Quantitative, three-dimensional analysis of granule cell dendrites in the rat dentate gyrus. J Comp Neurol 1990;302:206-19
48. Green EJ, Juraska JM. The dendritic morphology of hippocampal dentate granule cells varies with their position in the granule cell layer: A quantitative Golgi study. Exp Brain Res 1985;59:582-86 (Pubitemid 15042258)
49. Altman J, Bayer SA. Migration and distribution of two populations of hippocampal granule cell precursors during the perinatal and postnatal periods. J Comp Neurol 1990;301:365-81 (Pubitemid 20368500)
50. Bayer SA, Yackel JW, Puri PS. Neurons in the rat dentate gyrus granular layer substantially increase during juvenile and adult life. Science 1982;216:890-92 (Pubitemid 12058817)
51. Schlessinger AR, Cowan WM, Gottlieb DI. An autoradiographic study of the time of origin and the pattern of granule cell migration in the dentate gyrus of the rat. J Comp Neurol 1975;159:149-75
52. Wang S, Scott BW, Wojtowicz JM. Heterogenous properties of dentate granule neurons in the adult rat. J Neurobiol 2000;42:248-57 (Pubitemid 30055890)
53. Wu CC, Chawla F, Games D, et al. Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: Digital morphometric analyses. Proc Natl Acad Sci USA 2004;101: 7141-46 (Pubitemid 38596456)